Intellectual Property

  • March 19, 2025

    Special Master Suggests Sanctioning Irell In Patent Case

    Irell & Manella LLP should be sanctioned for the actions of an attorney who allegedly presented an altered document during a deposition for its client CogniPower LLC as part of the company's patent infringement lawsuit against Samsung Electronics, a special master in the case has recommended.

  • March 19, 2025

    Pillsbury Adds Commercial Deal Pro From A&O Shearman

    Pillsbury Winthrop Shaw Pittman LLP has expanded its global sourcing and technology transactions practice with the addition of the U.S. head of Allen Overy Shearman Sterling's digital, data, intellectual property and technology practice.

  • March 19, 2025

    Law360 Announces The Members Of Its 2025 Editorial Boards

    Law360 is pleased to announce the formation of its 2025 Editorial Advisory Boards.

  • March 18, 2025

    Miley Cyrus Must Keep Facing 'Flowers' Song Copyright Suit

    A California federal judge on Tuesday denied singer Miley Cyrus' bid to escape a lawsuit accusing her and her chart-topping "Flowers" co-writers of copying a Bruno Mars hit, rejecting arguments that the music investment company that filed the complaint couldn't sue because it isn't the sole owner of rights to Mars' song.

  • March 18, 2025

    Commerce Chief Removes USPTO Advisory Panel Members

    Commerce Secretary Howard Lutnick on Tuesday ended the terms of every member of two U.S. Patent and Trademark Office committees made up of individuals from outside the office who advise it on patent and trademark policies.

  • March 18, 2025

    Apple Arcade Accused Of Infringing Download Patent

    Apple was hit with a lawsuit Tuesday in Delaware federal court alleging its Arcade subscription service infringes a patent covering the process of searching for and downloading games.

  • March 18, 2025

    ITC To Review Whether Tourniquet Importers Are Ignoring Ban

    The U.S. International Trade Commission said that it is going to look into claims from a tourniquet maker that importers are ignoring a ruling last year that banned foreign counterfeit products.

  • March 18, 2025

    Music Publishers, Anthropic Fight Over Song Lyric Discovery

    Music publishers urged a California federal magistrate judge Tuesday to order artificial intelligence company Anthropic to produce certain song lyric data from both before and after Anthropic implemented "guardrails" to prevent Anthropic's AI tool "Claude" from outputting copyrighted lyrics, while Anthropic slammed the discovery request as overly broad.

  • March 18, 2025

    Let Patent Examiners Telework, Atty Group Tells Lutnick

    A trade group of patent lawyers is asking the U.S. Department of Commerce to maintain longtime "telework protections" for patent examiners in the wake of Trump administration initiatives to require in-person work.

  • March 18, 2025

    Netlist Slams Samsung's 'Abuse Of Power' As 3rd Trial Begins

    Samsung Electronics Co. engaged in a "raw abuse of power" when it breached the terms of a patent licensing agreement with chipmaker Netlist Inc., a jury heard Tuesday as the contract dispute went to trial for the third time in California federal court.

  • March 18, 2025

    Motorola Gets PTAB To Wipe Out Video Streaming Patent

    The Patent Trial and Appeal Board has ruled that Motorola has shown that all the challenged claims in a patent on providing access to video streams over a network are invalid, finding they were too obvious to warrant patent protection.

  • March 18, 2025

    Bausch Eye Vitamin Case Should Go To Jury, Judge Says

    The maker of eye care product MacularProtect shouldn't get a ruling clearing it from allegations it infringed Bausch & Lomb patents related to its PreserVision vitamin based on a doctrine allowing patent holders to claim infringement if an accused product is similar enough to the patented invention, a federal magistrate judge in Delaware has said.

  • March 18, 2025

    Fed. Circ. Says It Can't Review Realtek's ITC Sanctions Fight

    The Federal Circuit ruled Tuesday that the appeals court can't tell the U.S. International Trade Commission to explain why it declined Taiwan-based chipmaker Realtek Semiconductor Corp.'s request for a "sua sponte ruling" over a rival's alleged conduct in a dropped patent investigation.   

  • March 18, 2025

    AI Healthcare Co. Accuses Test-Maker Of Infringing Patents

    Artificial intelligence-powered diagnostics company Tempus AI has accused medical test-maker Guardant Health of infringing numerous patents related to healthcare records platforms and ways of pinpointing patient biomarkers.

  • March 18, 2025

    DraftKings Must Face Claims In MLB Players' NIL Suit

    DraftKings has failed to convince a Pennsylvania federal judge to toss a lawsuit against it claiming the company unlawfully used images of MLB players for promotional purposes, as the court rejected the argument that using the pictures was protected speech.

  • March 18, 2025

    NC Dance Teams' TM Feud Likened To MLB Rivalry At 4th Circ.

    An attorney for a North Carolina charter school on Tuesday used one of the biggest rivalries in Major League Baseball to illustrate for the Fourth Circuit how two former teachers stole its alleged dance team trademark and used pictures of the school's team to trick parents.

  • March 18, 2025

    Greenberg Traurig Boosts Litigation Team With 4 Denver Attys

    A team of four litigators have joined Greenberg Traurig LLP's growing Denver office, including a shareholder who was tapped to lead the office's litigation practice. 

  • March 18, 2025

    DC Circ. Denies Copyright For AI-Created Artwork

    The D.C. Circuit on Tuesday rejected an inventor's appeal to obtain a copyright for an artwork made by his artificial intelligence system, affirming the stance from the U.S. Copyright Office that the law protects only human creations.

  • March 17, 2025

    Novartis Nabs Partial Ban Against MSN's Heart Drug Generic

    Novartis AG succeeded Monday in blocking a competitor from potentially selling a similar-looking generic drug for treating heart failure, with a New Jersey federal judge remarking that MSN Laboratories Pvt. Ltd. "could have distinguished its pills," though she was less convinced that the name "Novadoz" was confusingly similar to "Novartis."

  • March 17, 2025

    ZoomInfo Says Rival's Employee Reviews Show Infringement

    Customer data platform company ZoomInfo has hauled its competitor Apollo.Io into Delaware federal court for allegedly infringing two of its patents, citing employee reviews on Glassdoor criticizing Apollo for copying and "cloning" rival products.

  • March 17, 2025

    Jonny Pops Can't Stop Rival's Suit Over '100% Real Fruit' Label

    A Texas federal judge refused to discard GoodPop's false advertising suit alleging Jonny Pops copied its popsicles and misleadingly labeled them as being made with "100% real fruit" and "simple ingredients" despite containing an unhealthy amount of added sugar, ruling Jonny Pops's statements, accompanied by images of fruit, could mislead consumers.

  • March 17, 2025

    Judge Ends Ex-Ga. Tech Prof's Suit Over Finance Probe

    Two Georgia Tech auditors have escaped a malicious prosecution suit from a former professor over allegedly suspicious financial dealings by his startup that they flagged, as a Georgia federal judge said the professor "failed to provide evidence" his rights were violated.

  • March 17, 2025

    NCAA, States Ask Judge To OK Deal On NIL Recruiting Rules

    A coalition of states and the NCAA asked a Tennessee federal judge to sign off Monday on a settlement that seeks to resolve antitrust litigation over the NCAA's ban on athlete recruits' name, image and likeness compensation, revealing new details of the deal, including a permanent bar on future policies.

  • March 17, 2025

    Gogo Says Rival Pivoted From Competing To Suing

    In-flight entertainment company Gogo Business Aviation wants out of a $1 billion lawsuit accusing it of wielding its monopoly over air-to-ground broadband tech to keep competitors at bay, telling the court that SmartSky is just trying to convert their intellectual property dispute into an antitrust one.

  • March 17, 2025

    New Bills Target 'Patent Thickets' And 'Product Hopping'

    A bipartisan group of senators is backing two bills it says will use the patent system to lower the price of prescription drugs, in part by targeting "patent thickets" and making "product hopping" a violation of antitrust laws. 

Expert Analysis

  • Private-Bidding Compliance Lessons From Siemens Plea Deal

    Author Photo

    Siemens Energy’s recent wire fraud conspiracy guilty plea shows that U.S. prosecutors are willing and able to police the private, domestic bidding market to protect the integrity of the competitive marketplace, and companies will need a robust compliance program to mitigate these risks, say attorneys at Foley Hoag.

  • Lessons From The Pharma Industry On Patent Cliffs

    Author Photo

    In the next five years, patents for drugs that have generated billions in global sales are set to expire, and companies that view this imminent patent cliff as an opportunity for strategic renewal rather than a challenge will be best positioned to maintain market leadership, says Keegan Caldwell at Caldwell Law.

  • FTC Report On AI Sector Illuminates Future Enforcement

    Author Photo

    The Federal Trade Commission's report on cloud service providers and their partnerships with developers of artificial intelligence's large language models suggests that the agency will move to rein in Big Tech with antitrust enforcement to protect startups, say attorneys at Squire Patton.

  • Artfully Conceding Liability Can Offer Defendants 3 Benefits

    Author Photo

    In the rare case that a company makes the strategic decision to admit liability, it’s important to do so clearly and consistently in order to benefit from the various forms of armor that come from an honest acknowledgment, says Ken Broda-Bahm at Persuasion Strategies.

  • Mentorship Resolutions For The New Year

    Author Photo

    Attorneys tend to focus on personal achievements or career milestones when they set yearly goals, but one important area often gets overlooked in this process — mentoring relationships, which are some of the most effective tools for professional growth, say Kelly Galligan at Rutan & Tucker and Andra Greene at Phillips ADR.

  • What Nearshoring Growth In Americas Means For Patents

    Author Photo

    With the new U.S. administration potentially focused on implementing draconian trade restrictions, nearshoring in the Americas is expected to grow, and patent prosecution attorneys will be kept on their toes as the patent landscape from country to country continues to evolve, says Ernest Huang at Procopio.

  • Series

    Coaching Little League Makes Me A Better Lawyer

    Author Photo

    While coaching poorly played Little League Baseball early in the morning doesn't sound like a good time, I love it — and the experience has taught me valuable lessons about imperfection, compassion and acceptance that have helped me grow as a person and as a lawyer, says Alex Barnett at DiCello Levitt.

  • Influencer IP Case Risks Judges Becoming Arbiters Of 'Vibes'

    Author Photo

    The case of Gifford v. Sheil, pending in Texas federal court, involves an influencer alleging that distinctive social media aesthetics constitute protectable property, and reflects a troubling trend: the overreach of intellectual property law in areas better left for creative freedom, say attorneys at Holland & Knight.

  • 5 Litigation Funding Trends To Note In 2025

    Author Photo

    Lawyers and their clients must be prepared to navigate an evolving litigation funding market in 2025, made more complicated by a new administration and the increasing overall cost of litigation, says Jeffery Lula at GLS Capital.

  • A Look At FDA's Plans To Establish New OTC Drug Category

    Author Photo

    The U.S. Food and Drug Administration's recently finalized rule, creating a new over-the-counter pathway for drugs when patients satisfy certain conditions, may be useful for off-patent drugs with established safety records, though switching to OTC comes with additional costs and considerations, say attorneys at Skadden.

  • The Fed. Circ. In 2024: 5 Major Rulings To Know

    Author Photo

    In 2024, the Federal Circuit provided a number of important clarifications to distinct areas of patent law – including design patent obviousness, expert testimony admissions and patent term adjustments – all of which are poised to have an influence going forward, say attorneys at Knobbe Martens.

  • Rethinking Litigation Risk And What It Really Means To Win

    Author Photo

    Attorneys have a tendency to overestimate litigation risk before summary judgment and underestimate risk after it, but an eight-stage litigation framework can clarify risk at different points and help litigators reassess what true success looks like in any particular case, says Joshua Libling at Arcadia Finance.

  • Patent Ruling Sheds Light On Printed Matter Doctrine

    Author Photo

    Patent attorneys should pay attention to the claim language highlighted in Ioengine v. Ingenico, where the Federal Circuit held that program code was not printed matter, but essentially instructions or content, and therefore not subject to the printed matter doctrine for patent challenges, says Irah Donner at Manatt.

  • How DOGE's Bite Can Live Up To Its Bark

    Author Photo

    All signs suggest that the Department of Government Efficiency will be an important part of the new Trump administration, with ample tools at its disposal to effectuate change, particularly with an attentive Republican-controlled Congress, say attorneys at K&L Gates.

  • US-China Deal Considerations Amid Cross-Border Uncertainty

    Author Photo

    With China seemingly set to respond to the incoming U.S. administration's call for strategic decoupling and tariffs, companies on both sides of the Pacific should explore deals and internal changes to mitigate risks and overcome hurdles to their strategic plans, say attorneys at Covington.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!